MEDCHEM 562P 2014 - VITAMINS and Minerals Part 1: Water Soluble Vitamins Bill Atkins Ph.D. H172Q, 685 0379; [email protected]INTRODUCTION I. Who takes vitamin/mineral supplements and why? [Bailey et al. JAMA Intern Med 173:355 (2013]. • It is estimated that ~50% of the adult population in the US takes some type of dietary supplement, typically to ‘improve/maintain overall health’. • >75% of products are used without care-provider recommendation.
39
Embed
MEDCHEM 562P 2014 - VITAMINS and Minerals Part 1: Water ...
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
MEDCHEM 562P 2014 - VITAMINS and Minerals
Part 1: Water Soluble Vitamins
Bill Atkins Ph.D. H172Q, 685 0379; [email protected] INTRODUCTION I. Who takes vitamin/mineral supplements and why? [Bailey et al. JAMA Intern
Med 173:355 (2013].
• It is estimated that ~50% of the adult population in the US takes some type of dietary supplement, typically to ‘improve/maintain overall health’.
• >75% of products are used without care-provider recommendation.
2
II. Multivitamins
It is estimated that ~30% of the adult US population take multivitamins daily. A recent clinical trial of male physicians taking multivitamins concluded there was a
very modest, but (statistically) significant, reduction in total cancers with daily multivitamin use (NEJM, 308:1871 (2012).
Do we need to supplement diets with vitamins/multivitamins? Maybe…. in certain circumstances.
Poor absorption -- elderly, GI disorders, specific GI surgeries, e.g. gallbladder
removal, gastric bypass, cystic fibrosis, severe diarrhea, drug-induced vitamin deficiencies – e.g. long term antibiotic use, cholestyramine, mineral oil
IV. Definitions
• Vitamins are organic compounds and minerals are chemical elements that are required as nutrients in small amounts by an organism.
• Vitamers are different forms of a particular vitamin, e.g. vitamins K1 and K2, vitamins D2 and D3, retinol and retinal, etc.
3
V. Reference Tables for Intake of Vitamins and Elements Intakes DRI Reports are produced by the Food & Nutrition Board of the Institute of
Medicine, National Academies of Science. http://fnic.nal.usda.gov/dietary-guidance/dietary-reference-intakes/dri-tables
Estimated average requirements (EAR): the average daily nutrient intake level estimated to meet the requirements of half of the healthy individuals in a group.
Recommended Dietary Allowance (RDA): the average daily dietary intake level; sufficient to meet the nutrient requirements of nearly all (97-98%) healthy individuals in a group. Calculated from the EAR.
Tolerable Upper Limit (UL): maximum adult daily intake unlikely to cause harm.
RDA= 1.2(EAR)
Daily Values (DVs) are set by the FDA.
http://ods.od.nih.gov/HealthInformation/dailyvalues.aspx • Two groups: Daily Reference Values (DRVs) for energy-producing nutrients,
e/g. fats, carbohydrates, protein etc. and Reference Daily Intakes (RDIs) for vitamins and minerals.
• A DV is often, but not always, similar to one's RDA for that nutrient. • DV is primarily used for labeling purposes. % DV on label is based on 2,000
calorie/day diet for adults and children over 4 yrs.
4
VI. Standardization
• Units of biological activity (IU) superceded, where known, by potencies based on weight (µg, mg) of the most active vitamer.
• IoM guidelines use weight. • FDA labels use both.
VII. History and Discovery 1500 BC Ancient Egyptians used liver - rich in vitamin A - applied to the eye to treat night
blindness.
1536 Jacques Cartier, exploring the St. Lawrence River, uses local native knowledge to save his men from scurvy by boiling the needles from cedar trees to make a vitamin C-rich tea.
1795 British navy adds lemons to sailors' rations, 40 years after a Scottish naval surgeon, James Lind, had urged that citrus fruits be used to prevent scurvy.
1884 Japanese navy eradicates beriberi - vitamin B1 deficiency- by feeding sailors meat and fruit in addition to polished white rice, which lacked the thiamine-rich husks.
1897 Beriberi (a polyneuritis) was induced in birds fed only polished rice and reversed by feeding the rice polishings.
1911 Casimir Funk isolates amine-containing concentrate containing thiamine from rice polishings, which was curative for polyneuritis in pigeons, and names it 'vitamine' for vital amine.
5
1912 Xavier Mertz –Antarctic explorer – dies of vitamin A poisoning from ingesting sled dog liver after supplies are lost in a crevasse.
Year discovered Vitamin Source
1912 Vitamin B1 Rice bran
1912 Vitamin C Lemons
1913 Vitamin A Milk/egg yolk
1918 Vitamin D Cod liver oil
1920 Vitamin B2 Eggs
1922 Vitamin E Wheat germ, Seed oils
1926 Vitamin B12 Liver
1929 Vitamin K Alfalfa
1931 Vitamin B5 Liver
1931 Vitamin B7 Liver
1934 Vitamin B6 Rice bran
1936 Vitamin B3 Liver
1941 Vitamin B9 Liver
6
VII. WATER SOLUBLE VITAMINS
A. Generalities 1. Metabolism and storage -- only B12 and folate are appreciably stored. In
general, water soluble vitamins are excreted readily and are not stored. As a result, depletion is more of a problem than toxicity.
2. Toxicity -- only niacin and pyridoxine are at all toxic (in high conc.). In general, the water soluble vitamins have few toxicities. The water soluble vitamins are coenzymes for various common biochemical reactions and their status can be readily determined by measuring the appropriate enzyme activities in blood. Typically, the enzyme activity is measured in the absence and the presence of exogenously added coenzyme, to determine whether the patient needs more of the vitamin.
B. Thiamin -- (Vitamin B1) 1. Structure
TMPN SCH2
CH3 N
N
CH3 CH2 CH2OH
Hthiamin
ATP ATPTPP
Chemically, the structure includes a pyrimidine ring and a thiazole ring. The thiazole ring has received enormous attention from mechanistic biochemists - they have pondered the reason for the choice by nature of a sulfur atom in the ring. Imidazole rings and oxazole rings would also, in principle, be capable of catalyzing the relevant chemical reactions.
Space-filling model of Thiamin
7
2. Function – used to harvest carbohydrates for energy a) Oxidative decarboxylation of α-keto acids
+
CH3 C CO2HO
TPP
lipoic acidNAD
CoASHpyruvate dehydrogenase complex
CH3 C SCoAO
CO2e.g. + + NADH
e.g. α -ketoglutaric acid TPP succinyl CoA CO2
NADCoASH
++
lipoic acidα-ketoglutarate dehydrogenase complex
8
The decarboxylation is accomplished by a mitochondrial enzyme complex as shown below. L = lipoic acid, E = enzyme, TPP = thiamin pyrophosphate. Pyruvate dehydrogenase complex in detail
b) Transfer of α-ketols (pentose phosphate pathway) -- 10% of carbohydrate metabolized this way. This pathway provides pentoses for RNA and DNA synthesis and NADPH for the biosynthesis of fatty acids and other endogenous reactions.
c) Non-coenzyme function – TTP involved in the control of chloride channels in brain and elsewhere in nerve impulse conduction.
E LSH
SH
CoASH
CH3 CSCoAO
NAD+
TCAcycle
E TPP
E TPP
C OH
CH3
(α-hydroxyethyl TPP)
E LS
S
E L SH
S C CH3O
CH3 C COOHO
CO2
NADH
CHOHCHO
CH2OPO3H2
+O=
HOCHCCH2OH
HCOH
HCOH
HCOHCH2OPO3H2
CHOHCHOH
CHOH
CHO
CH2OPO3H2
+O=
HO CHCCH2OH
HC OHCH2OPO3H2
TPPtransketolase
e.g.
xyulose-5-phosphate ribose-5-phosphate
sedoheptulose-7-phosphate
glyceraldehyde phosphate
9
3. Mechanism – formation of adduct with C2 of thiazole ring. ‘Classic’ experiments support this mechanism, including facile exchange of solvent D2O at the C-2 position.
4. Deficiency – thiamin needs are proportional to caloric intake and is essential for carbohydrate metabolism. Usually consider requirement as 0.5 mg/1000 calories plus 0.3 mg during pregnancy and lactation. Studies show laboratory evidence of thiamin deficiency (erythrocyte transketolase assay) in 20-30% of elderly patients and 40-50% of chronic alcoholics. <2% of healthy controls showed evidence of deficiency. a) Early signs of deficiency – anorexia, nausea, vomiting, fatigue,
weight loss, nystagmus, tachycardia.
b) Late signs of deficiency – Beriberi cardiac - increased heart size, edema cerebral - depression, irritability, memory loss, lethargy GI tract - vomiting, nausea, weight loss neurological - weakness, polyneuritis, convulsions. Signs and symptoms vary with age of patient, rapidity of onset, and severity of deficiency.
+H
+H
N S
CCH3
OH
NC
S
CHCH3
OH
NC
S
H
H+ + CH3 CHO
α-hydroxy-ethyl-TPP
H+
N S
CCH3 OH
C OO
3 2 H++NC
S
H
NC
S
CH3 C COOH
O
NC
Spyruvate
H+
CH3 C COOH
O
10
c) Thiamine and the alcoholic (i) intake low and alcohol blocks conversion of thiamin
→ TPP (ii) ↓ absorption - ↓ active transport (iii) ↓ storage (iv) increased fluid intake and urine flow causes thiamin
washout (v) involved in fetal alcohol syndrome.
d) Wernicke-Korsakoff syndrome – seen in some alcoholics;
neurological disorder resulting in impaired mental functioning → institutionalization for a significant number of patients. Symptoms: confusion, memory loss, confabulation, psychotic behavior; maybe irriversible in part.
f) Cellular uptake – Intestinal cells contain a thiamin specific
receptor/transporter (hTHTR) which appears to specifically pump thiamin and not TPP. After cellular uptake, thiamin is converted to TPP. Polymorphisms in the gene encoding hTHTR are known and may contribute to thiamin-responsive megaloblastic anemia. Once in the circulation specific transport proteins may ‘store’ TPP and control its circulation (hypothesized), but most is bound to Albumin. Most ends up in skeletal muscle, brain, heart, liver.
5. Source – present in most tissues (as TPP) and plants (as thiamin); rich sources include: lean meat, especially pork, cereal grains, eggs, yeast, nuts. Thiaminase – in some fish (raw) and shellfish (raw) and ferns. This enzyme can hydrolyze thiamin.
NC
SCH2R
In the milling or processing or processing of rice and flour, the thiamin is lost. ‘Whole’ wheat or rice contains ~10 times as much Thiamin as white wheat or rice. Today in the USA, most white flour, rice and pastas are "enriched" to bring thiamin levels to near original levels. "Enriched" products also have added riboflavin, niacin, iron, and folic acid.
11
6. Stability – labile at pH > 4 and when heated (especially at alkaline pH values) prolonged cooking ¯ levels especially at pH > 4.
7. Diagnosis of deficiency state a) ↑ pyruvate and lactate in plasma b) transkelotase activity in RBC – most important technique.
8. Uses
a) deficiency states -- for alcoholics b) thiamin responsive inborn errors of metabolism -- see below c) mosquito repellant -- efficacy? -- for dogs, for humans 50 mg QID
2d before and during exposure is recommended. d) acute alcoholism: give 100 mg IM or IV stat. This is a common
practice. e) Alzheimer’s disease—little evidence for benefit (huge doses used).
9. Thiamin responsive inborn errors of metabolism:
10. Requirement – 0.5 mg/1000 cal. DV = 1.5 mg. Minimum intake should be at least 1 mg.
11. Toxicity – nontoxic on oral administration; No UL value. Anaphylactic reactions have been observed in patients receiving repetitive parenteral doses.
12. Patient Counseling/ Patient Use Issues a) Needed to drive carbohydrates to energy b) Rarely needed as a single supplement. Use a multivitamin to get
needed thiamin. c) Special benefit in alcoholics at higher doses d) Benefit in high doses in rare thiamin-responsive inborn errors of
metabolism e) Uncertain benefit as a mosquito repellant (if true, 1-2 week onset) f) Nontoxic.
12
C. Riboflavin (Vitamin B2) Like Vitamin B1, Riboflavin is highly water soluble, and it is difficult to achieve toxic levels in the body – excess vitamin is efficiently eliminated renally. It used as an additive in many enriched foods and can be produced in huge, industrial scale, quantities by expression of the biodynthetic enzymes in fungi or bacteria. These genetically engineered organisms may appear bright yellowish-orange, which is the color of Riboflavin. 1. Structure
2. Function – redox, tissue respiration, H transfer as flavin containing enzyme. oxidized – yellow reduced - colorless Examples of enzymes having flavin groups: succinate dehydrogenase (-succinate → fumerate in TCA cycle) fatty acid acyl CoA dehydrogenase (β-oxidation of lipids) glutathione reductase – important in antioxidant activities The following are important flavoproteins (containing FMN): Cytochrome C reductase (electron transport); NADP+ -- cytochrome C reductase; cytochrome P-450 reductase (drug metabolism), flavin monooxygenase (drug metabolism).
3. Deficiency state a) Not usually seen in isolation but occurs in combination with other
B vitamin deficiencies. b) Fatigue, cheilosis, glossitis, vascularization of cornea, dermatitis c) Vegans and teenagers may be low in B2 if dairy intake is low d) Low B2 intake may be a risk factor for cataract development e) Alcoholics are at risk due to low intake and low absorption.
a) Usually > 30% destroyed by cooking b) Labile to light
red, colorlessox-yellow
R
NH
NH
HN
RO
O
RN
NNH
N O
O-2H⋅
⋅+2H
NADPH
NADP
FAD
FADH2
2GSH
GSSG
H2O2 or ROOH
2H2O or ROH + H2O
glutatione peroxidaseglutathionereductase
14
c) More stable in acid than alkali in absence of light.
6. Use a) Deficiency states. Is a component of most multivitamin mixtures. b) New – may help in migraine headache prevention. c) New – high intake associated with lower risk for cataracts and a
3mg supplement reduced risk.
7. Requirements a) DV = 1.7 mg b) “Average” U.S. diet contains 2 mg for males and 1.5 mg for
females c) Diagnosis – erythrocyte glutathione rreductase activity d) No UL value
8. Patient Counseling/ Patient Use Issues
a) Routine single dose supplementation not needed. Use a
multivitamin to get needed riboflavin. b) Possible use in preventing migraine headaches. Use 400 mg/d. c) Will turn urine bright yellow in doses higher than the DV. d) Nontoxic.
D. Vitamin B6 1. Structure
Pyridoxine is a commonly used term for this vitamin, but all 3 are equally active so vitamin B6 is a better term to use. Three phosphorylated forms are present also: P PO4 PLP
FMNPNP
FMN
pyridoxamine (PN)
N
CH2OHHO
CH3
CH2NH2
N
CH2OHCH2OHHO
CH3
pyridoxine (P)
N
CH2OHHO
CH3
CHO
pyridoxal (PL)
15
Coenzyme = pyridoxal-5-phosphate “PLP”
2. Function – participates in over 140 enzymatic reactions by forming a Schiff base with the terminal amino group of lysine in the enzyme. It is estimated that this corresponds to ~4% of all enzymatic reactions known. a) Transamination
e.g. glutamate-aspartate transaminase
N
CH2OP
CH3
HOCH
O
R NH2
holoenzymeNCH3
HO CH2OPCHNR
PLP
PLP dependent enzyme
+
R C COOHO
α-keto acid #1
N
HO CH2OP
CH3
CHNenzyme
N
HO CH2OP
CH3
CHNCHR COOH
N
HO CH2OP
CH3
CHNCR COOHH
N
HO CH2OP
CH3
CHNH2
R CH COOHNH2
amino acid #1
+
+
H2O
+ R´ C COOHNH2
amino acid #2
+ R´ C COOHO
α-keto acid #2N
CH2
NH2
HO
CH3
CH2OP
N
HO
CH3
CH2OPCHO
PLPPNP
PLP
oxaloacetic acid alanineCH3 CH COOH
NH2
transaminasepyruvic acid
HOOC CH2 C COOHO
+
aspartic acid HOOC CH2 CH COOH
NH2+ CH3 C COOH
O
16
b) Decarboxylation e.g. e.g. e.g. e.g.
Note: B6 contraindicated in levo-DOPA therapy because B6 enhances peripheral decarboxylation of levo-DOPA to dopamine which will not cross Blood Brain Barrier; Larobec® (Roche) contains no pyridoxine and can be used if multivitamin supplementation is desired for patient on l-DOPA. The anti-Parkinsons’s drug Sinemet® contains levo-DOPA and carbidopa (A DOPA
N
HO CH2OP
CH3
CHO
N
HO CH2OP
CH3
CHNCHR COOH
N
HO CH2OP
CH3
CHO
CH2RNH2+
decarboxylase
H2O
amino acid
R CH COOHNH2 + + CO2
HOOC CH2 CH2 C COOHH
NH2PLP
CO2
HOOC CH2 CH2 C HH
NH2
glutamic acid γ-amino butyric acid (GABA)
N
HOC COOHH
NH2
5-hydroxytryptophan
N
HOCH2
NH2
5-hydroxytryptamine (serotonin)
CO2
PLP
PLP
CO2NN
CH2HCH
NH2
histamine
NNCH2
HC COOHNH2
histidine
PLP
CO2 CH2 CH2
OH
NH2
HOHO
CH2HC COOHNH2
OH
DOPA DOPAMINE
17
decarboxylase inhibitor) -- therefore, no interaction.
c) B6 and sulfur amino acid metabolism. (Note: elevated homocysteine is an independent risk factor for cardiovascular disease and birth defects.)
d) B6 involvement in methionine formation (and S-adenosyl methionine) makes it indirectly involved in methylation. Hence B6 is indirectly involved in lipid metabolism and nucleic acid formation and immune function.
C COOHCH2
H
NH2
CH2SCH3
OCH2
S CH2NH2
HCH2 COOCH
adenine
OHOH
-
OCH2
CH3 S CH2 CH2 COOCH
adenine
OHOH
H
NH2
-
C COOHCH2
H
NH2
H3C
C COOHCH2
H
NH2
HS
α-ketobutyrate
cysteine
cystathionine
PLP serine
methionine
S-adenosylmethionine
methyl acceptor
S-adenosylhomocysteine
THFA
N5-methylTHFA
methyl B12
hydroxy B12
ATP
C COOHCH2
H
NH2
CH2HS
homocysteine
C COOHCH2
H
NH2
CH2S
CH2 C COOHH
NH2
+
PLPcystathionineγ-lyase
18
e) B6 involved in tryptophan metabolism to serotonin and niacin.
f) Other reactions requiring B6: (i) Glycogen phosphorylase (release of glucose in muscle) (ii) Heme biosynthesis
NiacinN
COOH
COOH
NH2NH
tryptophanoxygenase
serotonintryptophan
COOH
NH2NH
HO
N-formylkynurenine
NH2NCHO
COOH
O
3-hydroxykynurenine
NH2
COOH
OHNH2
O
kynureninasePLP
COOH
NH2OH
3-hydroxy anthranilic acid
NNH2
HO
Htryp
decarboxylase
PLP
19
(iii) Nucleic acid biosynthesis (via SAM)
SUMMARY of Pyridoxal/pyridoxamine reactions
CH2
N
C
N
HC
HC
N
N
B:
external imine internal imine
HO-
H2C
C
N
HN
OH
external carbinolamine
HC
HC
N
HN
HO-
OH
internal carbinolamine
H2C
N
NH2
OHC
N
O
NH2
hydrolysis of Imine leads to incorporation of ‘oxygen atom’ H2O attacks carbon atom of the imine, that carbon gets an oxygen PLP enzymes control which carbon atom gets the oxygen atom by switching between the external imine and the internal imine.
20
3. Deficiency
a) Not seen usually and, if seen, is associated with other vitamin
deficiencies or is iatrogenic; symptoms include rash, peripheral neuritis, anemia and possible seizures. Deficiency diagnosed by low plasma PLP and low transaminase activities (±PLP).
b) Iatrogenic B6 deficiencies (i) Isoniazid – antituberculosis drug – forms Schiff base with
B6. Can get neuritis and convulsions. 25-300 mg/d B6 given to prevent B6 deficiency.
5. Stability – pyridoxine is stable; some loss on cooking, especially with meats, due to Schiff base formation and decrease of the pyridoxal in the foods.
N
CO
NH NH2
N
HCO
CH2OHHO
CH3
+
N
CO
NH N CHO CH2OH
H
CH3
NIsoniazid
21
6. Diagnosis of Deficiency – measure erythrocyte transaminases.
7. Use a) Routine use in multivitamin products b) In INH therapy c) Certain inborn errors of metabolism
Name Symptoms Dose of B6 Problem
B6--dependent infantile convulsions
Clonic and tonic seizures
10-25 mg/day
Defective glutamic acid decarboxylase; possible GABA depletion
B6--responsive anemia
Microcytic, hypochromic anemia
100 mg/day
Defective hemoglobin synthesis
Xanthurenic acidurea Mental retardation 25-100 mg/day Defective tryptophan metabolism due to faulty kyureninase, xanthurenic acid spills into urine
Homocystinurea Mental retardation Early heart disease
25-500 mg/day Defective cystathionine synthetase homocysteine appears in urine
Cystathionurea Mental retardation 25-500 mg/day Defective cystathionase d) PMS (50-500 mg/d) -- evidence is uneven. PLP is known to bind
to steroid receptors.
e) Carpal tunnel syndrome -- evidence is uneven. It seems to work for some. A trial of B6 100-200 mg/d for 6 mos. may be worthwhile.
f) Use in lowering homocysteine levels (see sulfur amino acid scheme above). High homocysteine may be an independent risk factor for cardiovascular disease but this is now controversial. Combine with folic acid and B12 for optimum lowering action.
g) Nausea and vomiting in pregnancy-Helpful in high doses. PremesisRx contains 75mg sustained release B6 (plus 12ug B12, 1mg folic acid and 200mg calcium) or 25mg of generic B6 TID is less expensive.
8. Requirement – DV = 2 mg; UL = 100 mg.
9. Toxicity a) > 200 mg/day can decrease prolactin levels b) > 1-2 g/day can cause serious neuropathy by an unknown
mechanism. Recommendation: avoid long term use in doses above
22
200 mg.
10. Patient Counseling/ Patient Use Considerations a) Routine single dose supplementation usually not needed. Use a
multivitamin to get needed B6. b) Sometimes used, with limited evidence, for carpal tunnel
syndrome, PMS, and depression on OCs. c) Rare use in high doses for inborn errors. d) Sometimes used to prevent neuropathy with isoniazid. e) For nausea and vomiting of pregnancy, 25 mg TID or use
PremensisRx which is FDA approved for this. f) Used with B12 and folic acid in high homocysteine. g) Keep doses < 200 mg/d to avoid neuritis.
23
WATER SOLUBLE VITAMINS – PART 2 E. Folic Acid 1. Chemistry
coenzyme
DHFA
DHFA reductaseNADPHPABApteridine ring
Other "conjugates" existthat have more than oneglutamic acid; these havereduced vitamin activity.
N
N
N
NNH2
OHCH2
NH C NH CHO CO2H
CH2
CH2
COOH
N
N
HN
NH
OH
NH2
DHFA reductaseNADPH
= HH
CH2
H
NH R
THFA 2. Nomenclature Folic acid is pteroyl monoglutamic acid. This fully oxidized form is not found
naturally but is what is used in supplements. Reduced polyglutamates are found in animal and plant foods. Folic acid as a supplement or DHFA polyglutamates in foods are readily converted to the active fully reduced polyglutamates unless specific inhibitors are present (e.g. methotrexate).
Common use -- folates means all pteroglutamates having vitamin activity. Absorption, transport, circulation, storage -- dietary folates are enzymatically
cleaved by pancreatic and intestinal mucosal peptidases to the monoglutamate which is absorbed. Synthetic folic acid is well absorbed with a bioavailability of about 85%. Most of circulating folate is 5-methyl tetrahydrofolic acid (5-meTHFA). A considerable amount is excreted in the bile but most is reabsorbed. This continued enterohepatic circulation of folate is important for maintaining adequate levels and is interrupted by alcohol.
Other "conjugates" of DHFA and THFA that have more than one glutamic acid exist in foods; these are not as well absorbed as the oxidized monoglutamate
24
3. Function The folate cycle and methylation
(see belowfor detail)
ATP
C22 of purines
NH
NCHO
CH2
HN R
N5 formyl THFA"folinic acid""Leucovoran"
N
N
N
N
O
HCOOH
homocysteine
B12
THFAmethionine
CH2
NH R
H
N
N
HN
HH
NH
OH
C8 of purines
NH
NCH3
CH2
NH R
NH
N CH2
CH2 N R
NADH
N methyl THFA
N5N10methylene THFA
N10 formyl THFA
NH
NCH N R
CH2
NH
HN CH2
N RCHO
-H2O
NADPH2 N5N10 methenyl THFA
pyrimidinesN
NO
OCH3
thymine
822
876
9
105
43
21
(see B6lecture for details on thisimportant reaction)
MTHFR=methylene THFA reductase
OO
O
HN
NH2PO3O
OH OH
OO
O
HN
NH2PO3O
OH OH
CH3
deoxyuridinemonophosphate
deoxythymidinemonophosphate
thymidylate synthesis
N3-N10 methylene-THFA
DHFA
25
4. Folate deficiency
• Deficiency results in megabloblastic anemia. Symptoms include headache, fatigue, weight loss, anemia, nausea, anorexia, diarrhea, insomnia, irritability, forgetfulness. Signs are macrocytic red cells and megaloblasts in the bone marrow.
• Deficiency may result in teratogenesis with neural tube defects and possibly orofacial clefts. The importance of adequate folate intake at conception and for the first 3 weeks when the neural tube closes is obvious to few mothers. In 1992 the CDC, FDA, and NIH jointly recommended that "all women of childbearing age who are capable of becoming pregnant should consume 0.4 mg of folic acid per day as folic acid for the purpose of preventing neural tube defects." "Care should be taken to keep folate below 1 mg." “Enriched” grains now fortified with 140mg/100g to help decrease risk for birth defects.
• Defieciency may result in elevated homocysteine (HCS) which is associated with increased risk for coronary disease (and maybe the birth defects). Recent evidence indicates that a genetic polymorphism in the N5N10 methylene THFA reductase (MTHFR) enzyme is involved. Those with a C to T substitution in the gene coding for this enzyme (13%) are at high risk due to an enzyme of higher Km with resulting elevated HCS. This is the so called TT genotype.
• Oral contraceptives and anticonvulsant drugs use may increase folate catabolism.. This possibility seems to be behind the development of Beyaz, a combined oral contraceptive that includes progesterones AND 5-MTHF.
• Folate deficiencies are seen under conditions of poor nutrition, heavy alcohol ingestion and pregnancy and lactation.
• Alcohol decreases enterohepatic circulation of N5 methylTHFA. 5. B12 deficiency in relationship to folate B12 deficiency results in a folate deficiency because folates are not recycled
(see above folate cycle scheme). This is because 5-MeTHFA is not converted back to THFA in the absence of B12. Megabloblastic anemia therefore results from a deficiency of B12. Also, in a B12 deficiency, neurological damage is observed due to lack of B12 (see B12 discussion) which is hard to detect. Therefore high dose folate supplements are risky in cases where there is a possibility of pernicious anemia (B12 deficiency) because folate will mask hematological symptoms while neurological damage goes on unchecked. This is why preparations containing > 0.8 mg of folic acid are on Rx.
6. Folate antagonists a. Methotrexate -- ↓ DHFA reductase ∴ stops all in "S" phase cell cycle. Note: "Leucovoran rescue" technique allows ordinarily lethal dose to be
administered with consequent increased tumor kill. b. Trimethoprim --inhibits bacterial DHFA reductase and, combined with
sulfamethoxazole (Bactrim® Roche, Septra® BW), which is a PABA
26
antagonist, a "double hit" against bacterial folate metabolism is affected. There is usually very little effect on mammalian DHFA reductase.
c. Alcohol-affects enterohepatic circulation of folates
d. Nitrous oxide -- continued frequent inhalation has produced fatal megaloblastic hematopoisis and a neuropathy similar to pernicious anemia. The N2O oxidizes the cobalamin to create a B12 deficiency with resulting folate deficiency.
e. Phenytoin – suboptimal folate levels observed with long term therapy and rare megaloblastic anemia. BUT, folic acid (in high does) decreases phenytoin levels with cases of seizures reported.
f. Pyrimethamine- used for parasite infections (e.g. toxoplasma,malaria) as a parasite DHFA reductase target. Folic acid supplements may reduce effect of drug. Leucovorin is OK.
7. Use
a) Deficiency-use with oral contraceptives and during pregnancy and lactation.
b) To prevent neural tube defects in the unborn, women contemplating
pregnancy should take a supplement containing 0.4 folic acid, otherwise women of childbearing potential should assure that they are consuming at least 0.4 mg/day of synthetic folic acid (I suggest a multivitamin supplement).
c) Cervical dysplasia, brochial squamous dysplasia, and dysplasia of
colonic tissue in ulcerative colitis patients -- studies show elevated risk is associated with low folate.
d) Colon cancer - low folate , high alcohol, and low methionine
intakes as well as family history give an elevated risk. Long term use of multivitamins associated with lower risk (folate?).
e) breast cancer – high dietary intake decreases risk
g) coronary heart disease and stroke – elevated homocysteine associated with an increased risk but efficacy of folic acid, B12 and B6 to lower adverse outcomes are not well established. A modest effect may be evident (see B6 notes and discussion) especially for stroke. Those with preexisting disease show no benefit on outcomes for supplementation. Ongoing trials may clarify the situation.
8. Source
27
("Folic") leafy vegetables, fruit juices, beans; meats and most fruits are low.. "Enriched" flour now contains 140 µg/100 g of folic acid.
9. Stability Labile to light, heat, storage. Should try to eat some "fresh" vegetables.
Cooking losses are high (80-90%). 10. Dose
• Preparations containing greater than 0.8 mg are on Rx only. • DV = 0.4 mg of folate • The Food and Nutrition Board has set the requirement in DFE (dietary
folate equivalents) (see supplemental table). 1 DFE=1ug of food folate; 1ug of supplement folic acid =1.7DFE. On an empty stomach it is 2DFE.
a. A very important vitamin because inadequate intakes can increase risks for cancers, heart disease and stroke.
b. Rarely needed as a single supplement. Use a multivitamin to get needed folic acid. Benefit seen at levels in most multivitamins( 400ug/d) and the folic acid is very well absorbed. Folate rich foods (from which folate is less well absorbed) can supply the rest of intake.
c. Special benefit in alcoholics d. Use for those with elevated HCS in doses 0.8mg and higher. Use
together with B12 and B6. e. Intake of 400ug/d of supplement (multivitamin) is very important for
women of child bearing potential in order to help prevent birth defects.
f. Folic acid intake of >800ug/d is of concern in older populations due to the risk of masking pernicious anemia
28
F. Vitamin B12 1. Structure -- synthetic material is cyanocobalamin Coenzymes = 5 deoxyadenosine or methyl group replacing the CN; Hydroxy
cobalamin is also active.
Co
CN
base (5,6-dimethyl -benzimidazole)
1 amino-2-propanol
ribose
N CNN
N NCo
H3CH2NCOCH2
CH2CONH2CH3
CH2
H2CCH3
H2NCOCH2
HH3C
H2NCOCH2CH2CH3
CH3
CH3
CH3
HN
O PO
OO HO
O
N
N
CH3
CH3
HO
CH3
O
CH2CONH2
CH2CH2CONH2
Vitamin B12
29
2. Function a. Methyl transfer reactions
MethionineHomocysteine
N-5 methyl THFATHFA
methylcobalamin cobalamin
i.e. needed for recycling of THFA b. Metabolism of odd chain fatty acids
CH3 CH2 CSCoAO
CH3 CH C SCoA
O
O C O
H+
CO2
propionylCoA carboxylasebiotin
CH3 CH CSCoAO
COOHmethyl malonyl CoA
HOOC CH2 CH2 CSCoAO
succinyl CoA
B12mutase
excreted in urine asmethyl malonic acid in B12 deficiency
TCA cycle Note: 5-deoxyadenosyl cobalamin is the coenzyme form of B12 for this
reaction c. Myelin synthesis Mechanism of B12 involvement may relate to the buildup of methyl
malonic acid with a resulting decrease in myelin synthesis. B12 deficiency results in demyelination and neurological damage.
3. Deficiency -- pernicious anemia Symptoms related to inadequate myelin synthesis and megabloblastic anemia
due to failure to recycle folates; i.e., numbness, poor coordination, poor
30
memory, confusion, depression; at least 2-5 mg stored in liver and turnover is only 0.1% per day, therefore deficiency takes years to develop. Deficiency is rarely diet based, although vegans are at risk.
4. Absorption -- B12 absorption HCL in stomach splits B12 from peptide links in food; intrinsic factor (a
glycoprotein) secreted by stomach mucosa; required for transport of B12 across ileum wall (also requires Ca++ and a pH > 6 and releasing enzyme). Most of pernicious anemia is due to lack of synthesis of intrinsic factor and not due to dietary deficiency of B12. A simple B12 deficiency may be seen in older populations due to decrease in gastric HCl.
5. Source -- meats, especially liver and yeast; microorganisms are ultimate
sources of B12. 6. Production -- by fermentation. 7. Stability -- Stable at pH 4-7; labile to light. 8. DV = 6 µg. 9. Use In pernicious anemia, give 100 µg IM q 4 weeks; Studies indicate that 1
mg/day P.O. will work also. Sublingual 1mg “dots”may be better. A nasal solution 0.5mg/0.1ml) is marketed and is convenient. High IM doses are used for methylmalonic acidurea, an inborn error of metabolism.
Increasing interest in the role of B12 in keeping folic acid levels up and
homocysteine levels low. See folic acid lecture for the implications of high homocysteine and low folic acid.
Vegans should take supplements Those over 65 should take a supplement (multivit) due to decreasing HCl
needed for absorption of B12 from foods 10. Diagnosis: Schillings test (labeled B12) or better, measure methyl malonic
acid in plasma. Accurate diagnosis is important for rational therapy of anemias. 11. Preparations available In case of pernicious anemia usually given IM because patients often become
refractory to the intrinsic factor in oral preparations. High oral doses (>500ug/d), sublingual or nasal spray may obviate the need for IM injections. If problem is lack of HCl, po doses are OK. Long-acting form is hydroxycobalamin (Alpha redisol® MSD) -- dose is 100 µg/mo.
11. Toxicity -- essentially nontoxic
31
12. Patient Counseling/ patient use issues a. An important vitamin especially for older adults who may not absorb
B12 from foods efficiently due to low stomach acid or have pernicious anemia
b. B12 is important for maintaining adequate levels of folic acid in the body
c. Needed, together with B6 and folic acid, to keep HCS low d. An injection or special oral dosage forms needed to treat pernicious
anemia e. For most, the amounts contained in a good multivitamin will be
sufficient
G. Pantothenic Acid -- (Vitamin B5) 1. Chemistry
CH C NH CH2 CH2 CO2HOH
CHOH2CH3C O
H3C
d−α−hydroxy−β−β−dimethyl butyric acid
β−alanine
"CoASH"
β−mercaptoethylamine
O CH2 C C C NH CH2
H3C OH O
H3C
CH2ADP
Coenzyme = CoA
C NH CH2 CH2 SHO
Only the d-enantiomer has biological activity 2. Function -- as a thioester bond –A component of coenzyme A.- high energy
bond; 8,800 ca/mole; more than ATP -- used in transfer of acyl groups.
pyruvate acetyl CoA
NADTPPCoASH
3. Deficiency -- rare -- intestinal synthesis probably important, as well as,
widespread occurrence in foods. Symptoms are fatigue, numbness in extremities, cramps.
4. Use -- deficiency states -- topically for ulcers and sores, e.g. Panthoderm. 5. Requirements -- 10 mg = DV.
32
6. Source -- widespread in foods; liver, meat, eggs, potatoes are rich sources. 7. Properties -- alcohol or calcium salt somewhat more stable, therefore used in
vitamin preparations, stable at neutral pH, but not in acid or alkali.
8. Toxicity -- essentially nontoxic
9. Other—a dimmer (P-S-S-P) called pantethine is used in Europe as a drug to lower cholesterol. It is available in the USA as a dietary supplement. Seems safe and has mild effects in decreasing total cholesterol. Controversial use in treating acne.
10. Patient Counseling/ patient use issues Nothing special; deficiencies are very rare; is a component of most multivitamins
33
H. Biotin 1.
CHCH
CHN
O
S
NH
CHCH (CH2)4 CO2H
bound to enzymes through ε amino of lysine; dietary proteins are digested to lysine-biotin (biocytin) which is hydrolyzed by biotinase to release biotin. An inborn error with a defect in biotinase is known.
2. Function -- carboxylation reactions
e.g., acetyl CoAacetyl CoA carboxylase, biotin
malonyl CoA + Pi
lipids
CO2, ATP
e.g. pyruvate carboxylase- gluconeogenesis e.g. propionyl-CoA carboxylase – see B12 lecture carboxybiotin = active species
O C NC
NHO
O
3. Deficiency -- rare; rash, hair loss, fatty deposits on face, depression. 4. Requirement -- avidin (protein from egg whites) can precipitate deficiency
state → dermatitis, muscle pain, etc.; synthesized by intestinal flora. 5. Stability -- very stable. 6. Source -- eggs, meat, nuts are rich sources. 7. DV = 0.3 mg. 8. Use -- rarely used alone; several biotin responsive inborn errors of metabolism
are known, the most common being a defective biotinidase. Some use for brittle nails (mg doses and together with selenium (Diachrome) for improved glucose tolerance in diabetics
9. Patient Counseling/ patient use issues - nothing special; deficiencies are very rare; is a component of most multivitamins;
34
I. Niacin (Vitamin B3) 1. Chemistry
N
CO2H
niacinN
CNH2
O
niacinamide
O
HO
OH2C
OH
N
CNH2
O
coenzyme form is NAD or NADPADPorATP
(nicotinic acid)
2. Function -- >150 enzymes require NAD or NADP. a. redox and electron transport
H HCNH2
NR
O
R C C R´
H H
H H N
HCNH2
O
R
H++R C C R´H
H
+
b. ribosylation of proteins in cell signaling and DNA replication and repair
NAD + protein niacin + ADP-protein 3. Deficiency state - Pellagra - "4D's" dermatitis, diarrhea, dementia, death; red
tongue and pigmentation = common signs; seen in "corn belt" in U.S. during early 1900's, reason -- lack of available nicotinic acid and tryptophan in corn.
4. Biosynthesis -- See B6 section for biosynthesis of niacin from tryptophan. It is
estimated that 60 mg of tryptophan gives 1 mg of niacin. Isoniazid therapy can precipitate some symptoms of pellagra by binding up PLP and stopping the conversion of tryp to niacin.
5. Source -- meat, fish, whole grain cereals, peanuts. Ingested in foods as NAD
or NADP then hydrolyzed in the intestinal mucosa. 6. Stability -- very stable, but much is lost if cooking water is discarded. 7. Requirements -- DV = 20 mg, but requirement will depend on tryptophan
intake. UL=35mg
35
8. Use -- Component of multivitamin preps also used in high doses for its
pharmacological effects as described below. a. For improving serum lipids -- use Niacin (NA); Niacinamide is not
effective; NA used in doses up to 10 q/d (usually 3-5g), will lower LDL 5-25%, triglycerides 20-50% and raise HDL 15-35%. Combines well with statin drugs. Side effects are significant, but decrease with time. Mechanism: exact mechanism is unknown but does lower production of VLDLP and activates lipoprotein lipase. Niacin and some sustained release products are OTC. The extended release product (Niaspan) is Rx.
b. Schizophrenia – use of high dose niacin has been popular but is of
unproven efficacy.
c. Peripheral Vasodilator -- usefulness is questionable. d. Diabetes—there is interest in niacinamide in high doses to prevent type 1
diabetes in high risk kids and for type 2 adults. Niacinamide may help protect pancreatic beta cells but results showing benefit are preliminary.
9. Toxicity ( in doses over UL) -- peripheral vasodilation, flushing, GI upset,
ulcers, diarrhea, impaired glucose tolerance, liver damage (reversible?) and increased gout. These effects are seen with high doses (gram quantities) and decrease the usefulness of this vitamin for treating hyperlipidemias. Hepatitis has been associated more with the sustained release preparations of NA but not as much with the “extended release” product (Niaspan). The vasodilation and GI upset decreases after a few weeks on the drug. Aspirin and NSAIDS help. Niacinamide in high doses has significant associated adverse effects also but not the flushing reaction.
10. Patient counseling Issues
a) Single use is not necessary for nutritional purposes. Take a multivitamin.
b) High dose (gram quantities or Niaspan) are not for self medication because niacin can cause toxicity at doses needed for favorably affecting blood lipids.
36
J. Vitamin C (ascorbic acid) 1. Structure
(kidney stone risk?)
OO
OO
OHOH
dehydroascorbic acid
COHC
OHO
O
+ other metabolites
oxalic acid
OO
OO
OHOH
vitamin C oxidizedOO
OHOH
OHOH
vitamin C
–1e –1e
metabolism
2. Function -- true coenzyme function is not well understood; ascorbic acid is an
electron donor and facilitates the following reactions: a. Dopamine → norepinephrine b. Proline → hydroxyproline (this is a major component of
collagen and many of the signs of scurvy are due to impaired collagen synthesis).
c. Lysine hydroxylase → collagen. d. Folic acid → THFA (this explains the macrocytic anemia seen in
scurvy). e. Involved in absorption of iron (keeps in ferrous form for better
absorption). e. General water soluble antioxidant/free radical scavenger. We will
discuss this aspect in more detail later. a. Keeps LDL from being oxidized b. Possible regeneration of reduced vitamin E c. Prevent generation of mutagenic compounds in gastric juices and
elsewhere
Vitamin C as a free radical scavenger
37
3. Deficiency state → Scurvy Symptoms – hemorrhages, lassitude, weight loss, bone weakening, anemia,
edema, tooth loss. Biological lesion -- impaired collagen and connective tissue synthesis due to
lack of hydroxyproline, hydroxylysine. Also low THFA. 4. Utility of C a. In surgery and fractures -- to increase collagen synthesis. Probably helps. b. Common cold prophylaxis -- The books by Linus Pauling ("Vitamin C
and the Common Cold") and others have advocated that C has profound beneficial effects in preventing the common cold. Numerous clinical trials since 1970 show, at most, a slight beneficial effect. Ascorbic acid seems to cause a slight reduction in severity of colds, but the results are inconsistent from investigator-to-investigator. Gram quantities are not necessary, 100-500 mg/day will saturate tissues.
c. Cancer –diets with >200mg/d vitamin C are associated with lower
cancer risks, especially esophagus, stomach, colon and lung but studies using Vit C supplements have led to conflicting results.
38
d. heart disease—low dietary levels and low blood levels are associated
with an increased risk. Vitamin C supplements can modestly lower BP but no clear effect on outcomes in intervention studies. The benefit of supplements is unclear unless one is deficient in Vitamin C
e. ataracts-higher intakes show lower risks but the benefit of intervention with supplements is not proven.
5. Storage -- is present in most tissues at low levels; there is a threshold level
above which excess is excreted. This is about 200mg/d. 6. Source -- richest sources are not citrus juices, but broccoli, brussel sprouts,
peppers; other items high in ascorbate are citrus products, potatoes, and tomatoes. Cereal products, grains, and meats contain very little; if 5 fruits or vegetables are eaten daily, the intake would be 250 mg., average intake is about 75 mg./day.
7. Stability -- in solution is relatively unstable being oxidized by air and being
photolabile, therefore, much C can be destroyed in cooking foods. 8. Toxicity -- Essentially nontoxic; in gram doses may increase oxalate urine
concentrations and subsequent increased risk for urinary stones. Will make urine tests for sugar unreliable (false positive) because C will reduce the copper in Clinitest and Benedicts solution; In doses over 250mg/d can make false negative haemoccult test for blood in stool; contraindicated when have iron overload.
9. Requirements -- DV = 60 mg. but is this intake optimum for best health??
New RDA is 75mg for females and 90mg for males and 125mg for smokers. UL=2g/d
10. Bioavailability of various products. AUC-PO/AUC-IV is true bioavailability studies should be done at steady state 200 mg. = 80% bioavailability 500 mg. = 63% bioavailability 1250 mg. = 46% bioavailabililty at > 500 mg/d all of the absorbed ascorbate was excreted in the urine conclusions: best dose is 200-500 mg/d timed release products, Ester-C (calcium ascorbate) or esters of vitamin C are
not worthwhile 11. Patient Counseling Issues
a) The benefits of taking high doses (>200mg) of vitamin C are not established
b) Most multivitamins provide 60mg/dose which may be too low for optimum benefit
c) Daily consumption of a glass of rehydrated frozen OJ will, when taken with a
multivitamin, will give saturation levels (~200mg) of C d) Studies to date indicate the value of eating ample fruits and vegetables
to
39
help prevent cancers and heart disease. The use of a multivitamin may also
help. e) synthetic vitamin C is the same as natural vitamin C f) Use of high doses to prevent or treat the common cold is unwarranted.
Doses of ~200mg may slightly reduce severity of the cold.